Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor
Background: We present the case of a 64-year-old patient who presented to his primary care physician with fatigue, worsening shortness of breath, abdominal discomfort and a rapidly growing abdominal girth, although he had lost 5 kg of weight within 3 months. He had a history of untreated hypertensio...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2009-08-01
|
| Series: | Case Reports in Oncology |
| Subjects: | |
| Online Access: | http://www.karger.com/Article/FullText/231972 |
| _version_ | 1818893628351709184 |
|---|---|
| author | Sascha Dietrich Gerlinde Egerer Anthony D. Ho Bernd Kasper |
| author_facet | Sascha Dietrich Gerlinde Egerer Anthony D. Ho Bernd Kasper |
| author_sort | Sascha Dietrich |
| collection | DOAJ |
| description | Background: We present the case of a 64-year-old patient who presented to his primary care physician with fatigue, worsening shortness of breath, abdominal discomfort and a rapidly growing abdominal girth, although he had lost 5 kg of weight within 3 months. He had a history of untreated hypertension, compensated renal insufficiency and COPD. Despite weight loss and fatigue, the patient did not experience any other constitutional symptoms such as fever, night sweats or loss of appetite. Investigations: Physical examination, blood tests, CT scan of the abdomen, MRI scan of the abdomen, fine needle biopsy, excisional biopsy, Video Capsule Endoscopy, histology, PET scan. Diagnosis: Inflammatory myofibroblastic tumor, chylous ascites, chyloperitoneum. Management: Systemic chemotherapy, total parenteral nutrition and octreotide therapy. Conclusion: We describe the case of a patient in whom two extremely rare phenomena are present in combination: the diagnosis of an inflammatory myofibroblastic tumor and chylous ascites. While the tumor could be stabilized by different regimens of chemotherapy, the chyloperitoneum was treated with parenteral nutrition and subcutaneous octreotide injections, which resulted in a significant reduction of the amount of chylous ascites drained during regular paracentesis. |
| first_indexed | 2024-12-19T18:15:37Z |
| format | Article |
| id | doaj.art-95d1054c84e24af2bc9aada45adc59bd |
| institution | Directory Open Access Journal |
| issn | 1662-6575 |
| language | English |
| last_indexed | 2024-12-19T18:15:37Z |
| publishDate | 2009-08-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Case Reports in Oncology |
| spelling | doaj.art-95d1054c84e24af2bc9aada45adc59bd2022-12-21T20:11:08ZengKarger PublishersCase Reports in Oncology1662-65752009-08-012214414910.1159/000231972231972Chylous Ascites in a Patient with Inflammatory Myofibroblastic TumorSascha DietrichGerlinde EgererAnthony D. HoBernd KasperBackground: We present the case of a 64-year-old patient who presented to his primary care physician with fatigue, worsening shortness of breath, abdominal discomfort and a rapidly growing abdominal girth, although he had lost 5 kg of weight within 3 months. He had a history of untreated hypertension, compensated renal insufficiency and COPD. Despite weight loss and fatigue, the patient did not experience any other constitutional symptoms such as fever, night sweats or loss of appetite. Investigations: Physical examination, blood tests, CT scan of the abdomen, MRI scan of the abdomen, fine needle biopsy, excisional biopsy, Video Capsule Endoscopy, histology, PET scan. Diagnosis: Inflammatory myofibroblastic tumor, chylous ascites, chyloperitoneum. Management: Systemic chemotherapy, total parenteral nutrition and octreotide therapy. Conclusion: We describe the case of a patient in whom two extremely rare phenomena are present in combination: the diagnosis of an inflammatory myofibroblastic tumor and chylous ascites. While the tumor could be stabilized by different regimens of chemotherapy, the chyloperitoneum was treated with parenteral nutrition and subcutaneous octreotide injections, which resulted in a significant reduction of the amount of chylous ascites drained during regular paracentesis.http://www.karger.com/Article/FullText/231972Octreotide therapyChyloperitoneumChylous ascitesInflammatory myofibroblastic tumor |
| spellingShingle | Sascha Dietrich Gerlinde Egerer Anthony D. Ho Bernd Kasper Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor Case Reports in Oncology Octreotide therapy Chyloperitoneum Chylous ascites Inflammatory myofibroblastic tumor |
| title | Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor |
| title_full | Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor |
| title_fullStr | Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor |
| title_full_unstemmed | Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor |
| title_short | Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor |
| title_sort | chylous ascites in a patient with inflammatory myofibroblastic tumor |
| topic | Octreotide therapy Chyloperitoneum Chylous ascites Inflammatory myofibroblastic tumor |
| url | http://www.karger.com/Article/FullText/231972 |
| work_keys_str_mv | AT saschadietrich chylousascitesinapatientwithinflammatorymyofibroblastictumor AT gerlindeegerer chylousascitesinapatientwithinflammatorymyofibroblastictumor AT anthonydho chylousascitesinapatientwithinflammatorymyofibroblastictumor AT berndkasper chylousascitesinapatientwithinflammatorymyofibroblastictumor |